Background Traditionally, after prenatal diagnosis of hypoplastic left-hear
t syndrome (HLHS) couples have been offered termination of pregnancy or com
fort care. Success of postnatal surgical options such as the Norwood proced
ure have been associated with survival of up to 60%. Whether survival is af
fected by the congenital anomaly being identified prenatally or postnatally
remains uncertain.
Methods We reviewed all cases of prenatally diagnosed HLHS referred to the
Fetal Medicine Unit at Birmingham Women's Hospital over 6 years between 199
4 and 1999.
Findings 87 cases of HLHS were referred at a median gestational age (95% CI
) of 23 (19-37) weeks. Of these, 53 (61%) chose prenatal karyotyping. The o
verall frequency of abnormal karyotype was found in seven of 59 cases (12%)
and associated structural anomalies in 18 of 87 (21%). After counselling,
38 of 87 couples (44%) chose termination of pregnancy. Of the remaining 49
fetuses, 11 (23%) were not considered for postnatal surgery because of pare
ntal choice and they died after compassionate care. Of the 36 babies who ha
d surgery postnatally, 12 survived (33%). We recorded a survival rate of 38
% for the stage-1 Norwood procedure in the prenatally diagnosed HLHS in our
centre. These data suggest that at the point of prenatal detection, the ov
erall survival rate for fetuses with HLHS is 25% (if terminated pregnancies
are excluded).
Interpretation Fetal echocardiography allows early diagnosis of HLHS and gi
ves clinicians the opportunity to triage this group dependent on prenatal f
indings, including karyotyping and the exclusion of other structural anomal
ies. These prospective data provide up-to-date information on the basis of
which parents can make decisions.